Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection

(RCSI) New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness of the risk among doctors.